Company
Novascan
Real-Time Surgical Margin Assessment
Also known as Novascan Inc., NovaScan LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- NovaScan LLC
Claim, correct or request removal
Record updated 29 September 2026
About
Easy to use, ex vivo and in vivo cancer detection that provides instantaneous, highly accurate results, without expensive capital equipment.
Funding snapshot
- Total raised
- $3.7MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant, $3.7M2025-11-22
Funding rounds
- Round, 2026
- $671K2026-04-28, SEC form D sold, 4 investors
- Grant
- $3.7M2025-11-22, Company stated
- Round, 2022
- 2022-11-29
- Round, 2021
- 2021-10-25
- Round, 2020
- $100K2020-09-02, SEC form D sold, 4 investors
- Round, 2017
- $50K2017-07-10, SEC form D sold, 1 investor
Products
- Hardware
- MarginScan
Loading relationship preview